Allianz, Pours

Allianz Pours Nearly €1bn Into Buybacks, but Technical Resistance Stalls the Share Price

05.06.2026 - 21:14:33 | boerse-global.de

Despite €1bn spent on share repurchases by end of May, Allianz shares remain 6% below 52-week high, with key resistance at €378.81 and support at €366.60.

Allianz Buyback Machine Runs Full Throttle, Stock Stuck in Narrow Range
Allianz - Allianz Pours Nearly €1bn Into Buybacks, but Technical Resistance Stalls the Share Price 05.06.2026 - Bild: über boerse-global.de

The Allianz buyback machine is running at full throttle, yet the share price remains stuck in a narrow range. By the end of May, the insurer had already spent close to €1bn on repurchasing its own stock — roughly 40% of the €2.5bn programme that kicked off on 13 March. A total of 2.65 million shares, equivalent to 0.7% of the outstanding capital, have been bought so far, with the last week of May alone adding 385,000 shares for €149m. The plan is to cancel these shares, boosting earnings per share without any improvement in underlying profits.

The stock, however, has failed to respond. It recently changed hands at €372.40, recovering to €373.00 by Friday’s close for a marginal 0.35% gain. That leaves it roughly 6% below the 52-week high of €397.00 set on 21 April. The weakness extends across shorter timeframes: a seven-day decline of 2.23% and a one-month drop of 5.26%. The immediate question is whether the buyback momentum can finally push the shares through a wall of technical resistance.

On the chart, Allianz is sandwiched between two key moving averages. The 200-day line at €370.31 was crossed to the upside on 4 June after a brief dip below it, but the stock now sits just 0.56% above that level. The 50-day average at €378.81 — roughly 1.5% above the current price — acts as a firmer ceiling, with the 100-day average at €373.70 providing an immediate hurdle. The relative strength index (RSI) hovers around 43, split between 42.9 and 43.6 in the two reports, indicating tepid buying interest but no oversold conditions. A sell signal from the three-month MACD adds to the caution, while the 30-day annualised volatility of 23.62% reminds investors that defensive insurance stocks can still swing.

Should investors sell immediately? Or is it worth buying Allianz?

Below the 200-day line, the next meaningful support sits at €366.60. A break lower would put the 52-week trough of €332.80 from June 2025 back in play, about 12% below current levels. The risk-reward balance looks constrained: the stock trades closer to the €377 resistance zone than to the €355 support. On a year-to-date basis, Allianz is down 4.19%, though the 12-month performance remains positive at just over 5%.

The buyback programme rests on solid fundamentals. First-quarter 2026 operating profit climbed 6.6% to €4.5bn, business volume expanded to €53bn, and the solvency ratio strengthened to 221%. Management reaffirmed the full-year operating profit target of €17.4bn, plus or minus €1bn, providing the financial firepower to continue repurchasing at a rapid clip.

The next major catalyst comes with the release of second-quarter results on 6 August 2026, followed by half-year figures on 7 August. Until then, the progress of the buyback remains the most verifiable signal for investors. A sustainable close above the 50-day moving average at €378.81 would brighten the technical picture and open the path back toward the €397 resistance. Should the stock slip back below the 200-day line at €370.31, the recent recovery will quickly lose credibility.

Ad

Allianz Stock: New Analysis - 5 June

Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Allianz analysis...

en | DE0008404005 | ALLIANZ | boerse | 69489759 |